Friday, March 31, 2017

Antivirals may cure HCV–associated B-cell lymphoma, case study finds

Healio - Hepatitis C 
Antivirals may cure HCV–associated B-cell lymphoma, case study finds
March 31, 2017
Treatment with direct-acting antivirals may result in remission of hepatitis C virus-associated lymphoma, researchers suggested.

The case study’s findings suggest that “elimination of the causative pathogen could be essential for the treatment of HCV-associated NHL even without an interferon (IFN)–based treatment,” they added.

From May to August of 2016, the patient received daily doses of the DAA combination Harvoni (sofosbuvir/ledipasvir, Gilead Sciences) to treat HCV. The researchers reported no major complications.

Continue reading....

No comments:

Post a Comment